In chronic systolic heart failure and conduction system disease, cardiac resynchronization
therapy (CRT) is the only known non-pharmacologic heart failure therapy that improves …

Non-response to cardiac resynchronization therapy remains a significant problem in up to
30% of patients. Multisite stimulation has emerged as a way of potentially overcoming non …

Aims To assess the impact of MultiPoint™ Pacing (MPP)—programmed according to the
physician's discretion—in non-responders to standard biventricular pacing after 6 months …

Aims Pacing from multiple sites in the left ventricle (LV) may bring about further
resynchronization of the diseased heart compared with biventricular (BiV) pacing. We …

Abstract Objectives: The MultiPoint Pacing (MPP) trial assessed the safety and efficacy of
pacing 2 left ventricular sites with a quadripolar lead in patients with heart failure indicated …

Background—Electrophysiological cardiac devices are increasingly used. The frequency of
subclinical infection is unknown. We investigated all explanted devices using sonication, a …

Aims A significant proportion of patients implanted with biventricular (BiV) devices fail to
respond. Clinical response may be improved by additional ventricular stimulation sites. This …

Cardiac resynchronization therapy (CRT) is currently an established device therapy for heart
failure (HF) patients. Cumulated knowledge on the pathophysiological mechanisms …

Multipoint LV Pacing Improves Mid‐Term CRT Response Introduction Cardiac
resynchronization therapy (CRT) with multipoint left ventricular (LV) pacing in a single …

USPC............................................ 607.9, 14, 15.25 avoid capture problems due towavefront
propagation, such as fusion or lack of capture. MSLV pacing delays are then set to See …